REGULATORY INTELLIGENCE·Warning Letter
Novocol Pharmaceutical's Mepivacaine HCl Recall: Critical Supply Chain Risks for Dental Anesthetics
Novocol Pharmaceutical of Canada, Inc. has initiated a voluntary Class II recall of Mepivacaine Hydrochloride Injection due to defective cartridges. This event, impacting U.S.A. nationwide distribution, poses immediate supply chain risks for dental anesthetic procurement. Decision-makers must assess inventory, identify alternative sourcing strategies, and prepare for potential market shortages of this essential pharmaceutical.
90-Day Activity